Timil Patel, MD

Executive Medical Director @EliLillyandCo. Former @FDAOncology.

[Timil Patel, MD @timilpatel]

@DrRoyHerbst @DartmouthCancer @GeiselMed Congrats Dr Herbst!

[Timil Patel, MD @timilpatel]

@PamelaKunzMD @YaleMed @YaleCancer @ericwiner @ROYHERBST Congratulations!!

[Timil Patel, MD @timilpatel]

@pkluetz giving an @FDAOncology perspective on DCT and pragmatic trials on the heels of recent published FDA guidances @CancerResrch.

Every trial can integrate pragmatic and DCT elements, and the degree would be context dependent on the disease setting & treatments involved.

[FDA Oncology @FDAOncology]

Recently we welcomed more than 40 fellows to FDA—in collaboration with @ASCO—for an educational workshop, now in its 10th year. An additional almost 100 fellows joined virtually. What a great group! #OncEdFellows #OCEProjectSocrates #MedEd

[FDA Oncology @FDAOncology]

FDA approves neoadjuvant/adjuvant nivolumab for resectable non-small cell lung cancer without EGFR mutations or ALK rearrangements.
https://t.co/VE3c5Zs5EO

#OCENewsBurst #lcsm

[FDA Oncology @FDAOncology]

FDA approves osimertinib for locally advanced, unresectable (stage III) non-small cell lung cancer following chemoradiation therapy.
https://t.co/JjOn54M3xA

#OCENewsBurst

[Tatiana Prowell, MD @tmprowell]

NEW 📣Final FDA Guidance on decentralized #clinicaltrials is out! Covers local labs, imaging, procedures; local healthcare providers; telehealth; informed consent; inv product delivery/accountability; & data mgmt.

#MedTwitter #regulatory #DrugDevelopment

https://t.co/PoejYr1CRJ

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

Its here!

@US_FDA guidance on Conducting Clinical Trials With Decentralized Elements is out!

Protocols should specify whether
- Telehealth visits is appropriate
- Local health care providers can conduct study visits

https://t.co/2xObvs2aGT

[FDA Oncology @FDAOncology]

FDA approves lazertinib in combination with amivantamab-vmjw for locally advanced or metastatic non-small lung cancer with specific EGFR mutations.

https://t.co/fxHlXvykLa

#OCENewsBurst #lcsm

[AACR @AACR]

A @CCR_AACR article highlights how the FDA-AACR Oncology Educational Fellowship helped four alumni develop their career trajectories. Applications for the next class of fellows are open through Aug 1. Learn more:
https://t.co/BzLosL5ko2
#AACRSciencePolicy @timilpatel @HadidiSamer

[Danielle Carnival Archived @DCarnival46]

Beginning tomorrow, the Cancer Cabinet that @POTUS created to end cancer as we know it - will host a series of virtual conversations highlighting key actions driving progress on priorities for the #BidenCancerMoonshot.

Join us! https://t.co/aRmkqjRDyu

[OncoDaily @oncodaily]

Career Development Beyond the @FDAOncology-AACR Oncology Educational Fellowship
@CCR_AACR @timilpatel @drjennifergao
https://t.co/Ud9ej4ZKjk

#Cancer #CancerResearch #FDAOncology #AACR #OncoDaily #Oncology

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

Check👇

Reflections and Roadmaps: Career Development Beyond the FDA-AACR Oncology Educational Fellowship @HemOncFellows @FDAOncology @timilpatel @drjennifergao @ChrisChenMD Yasmin Kadry @UAMSMyeloma @CCR_AACR

➡️ https://t.co/aGQrpFwmcz

A great program, highly recommended

[FDA Oncology @FDAOncology]

Reflections and Roadmaps: Career Development Beyond the FDA-AACR Oncology Educational Fellowship - via @CCR_AACR
✔️ Transformative experience
✔️ Regulatory deep dive
✔️ Mock ODAC
💯 Unique opportunity!
https://t.co/YVP7UNRt34
@timilpatel @drjennifergao
#MedEd #OCEProjectSocrates

[The Lancet Oncology @TheLancetOncol]

Online First:
Effect of #ProjectOrbis participation by the Swiss regulator @Swissmedic_ on submission gaps, review times, and drug approval decisions between 2020 and 2022: a comparative analysis
#cancerdrugs
https://t.co/qG4voA3nsT

[Timil Patel, MD @timilpatel]

@TimothyJBrownMD @lungoncdoc @ADesaiMD @FawziAbuRous @BrunaPellini @drshieldsmd @ShrutiPatelMD @Tony_Calles @marklewismd @jillfeldman4 @LeciaSequist @ASCO @ShaalanBeg @realbowtiedoc 🤣🤣

[Pearl Freier @PearlF]

FDA medical oncologist @timilpatel is joining the @DTRAorg gang for a Tues chat to discuss recent #asco24 abstract re: adoption of decentralized trial elements in cancer clinical trials during pandemic. @CTTI_Trials & FDA collected data from research sponsors h/t @akalali 1/n

[Vivek Subbiah, MD @VivekSubbiah]

⭐️Honored to meet with the visionary Dr. @realrickpazdur whose insights have always inspired me through all these years. It was such an incredible @ASCO !🏆
Working in oncology clinical trials now is amazing, with advancements in #PrecisionMedicine, immunotherapy, ADCs, & much much more. #ASCO24

[Timil Patel, MD @timilpatel]

@Anand_88_Patel Congrats!!

[CTTI @CTTI_Trials]

#CTTI is proud of the contributions Sabrena Mervin-Blake, Sara Bristol Calvert, & Amy Corneli made to this groundbreaking study!